Evommune, Inc.: president & CEO Luis C. Pena received 1,115 shares

What happened

• The filing says Luis C. Pena, president & CEO and director, acquired 1,115 shares on Sep 30, 2026, at $7.02 per share, for $7,827. The transaction is reported on a Form 4 filed Oct 15, 2026.

Key details

• Transaction date and price: Sep 30, 2026 — 1,115 shares acquired at $7.02 per share.
• Filing date and period: Form filed on Oct 15, 2026; period of report Sep 30, 2026.
• Shares owned after the transaction: the filing does not report shares owned after the transaction.
• Footnotes from the filing:
  • F1: shares were acquired under the non-qualified component of the Evommune, Inc. 2025 Employee Stock Purchase Plan (ESPP).
  • F2: shares were purchased at 85% of the closing price of the issuer's common stock on Sep 30, 2026.
• Filing timeliness: reported late (transactionTimeliness = 'L'); the filing says the delay was due to an administrative oversight.

Why it may matter

• The filing shows an acquisition under the company's ESPP, which is not a market sale.
• A filing does not show why the insider traded or why the company acted.